Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Thyroid cancer, Hurthle cell 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Adenocarcinoma, Follicular 1

Interventions

Blood Specimen Collection 19Surveys and Questionnaires 16Specimen Handling 15Radiotherapy 6Magnetic Resonance Spectroscopy 6trastuzumab deruxtecan 5Surgical Procedures, Operative 5Observation 5darolutamide 4Patient Reported Outcome Measures 4Magnetic Resonance Imaging 4Data Collection 4Cryosurgery 4Breath Tests 4ribociclib 3atezolizumab 3Watchful Waiting 3Ultrasonography 3Tomography, X-Ray Computed 3Standard of Care 3Radiation 3Letrozole 3Interviews as Topic 3Immune Checkpoint Inhibitors 3Hepatectomy 3Biopsy 3Bevacizumab 3palbociclib 2lorlatinib 2cemiplimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × gallium Ga 68 dotatate × 30 days × Clear all
NCT00001160 2026-05-12

Studies on Tumors of the Thyroid

National Institutes of Health Clinical Center (CC)

Recruiting
2,500 enrolled
EndocrineHead & Neck

Thyroid cancer, Hurthle cell, Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡